SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Fredun Pharmaceuticals informs about board meeting

09 Dec 2023 Evaluate

Fredun Pharmaceuticals has informedthat the meeting of the Board of Directors of the Company is scheduled on16/12/2023 ,inter alia, to consider and approve for fund raising upto Rs. 120crores by way of further public offer, right issue, ADR/GDR/FCCB, QIP, Debtissue, preferential issue or any other method.

The above information is a part of company’s filingssubmitted to BSE.

Fredun Pharma Share Price

2055.40 11.50 (0.56%)
22-Apr-2026 10:53 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1653.80
Dr. Reddys Lab 1215.95
Cipla 1228.20
Zydus Lifesciences 927.75
Lupin 2307.30
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×